Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Working Capital Changes (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Working Capital Changes for 4 consecutive years, with $43217.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes rose 2596.65% to $43217.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $127759.0, a 1022.71% increase, with the full-year FY2024 number at $105594.0, up 219.42% from a year prior.
  • Other Working Capital Changes was $43217.0 for Q3 2025 at bioAffinity Technologies, up from -$23260.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $530481.0 in Q3 2022 to a low of -$161445.0 in Q2 2023.
  • A 4-year average of $42994.4 and a median of -$5192.0 in 2023 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: plummeted 840.77% in 2023, then soared 2596.65% in 2025.
  • bioAffinity Technologies' Other Working Capital Changes stood at -$9424.0 in 2022, then skyrocketed by 44.91% to -$5192.0 in 2023, then skyrocketed by 2300.46% to $114248.0 in 2024, then plummeted by 62.17% to $43217.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Other Working Capital Changes are $43217.0 (Q3 2025), -$23260.0 (Q2 2025), and -$6446.0 (Q1 2025).